TCM
MBOT icon

Tradewinds Capital Management’s Microbot Medical MBOT Stock Holding History

Tradewinds Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-591
Closed -$3K – 688
2020
Q1 		$3K Buy
+591
New +$5.18K ﹤0.01% 504
2017
Q3 		– Sell
-3
Closed – – 680
2017
Q2 		$0 Buy
+3
New +$166 ﹤0.01% 685

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tradewinds Capital Management's MBOT Position: Q2 2020 in Review

Tradewinds Capital Management sold out of Microbot Medical (MBOT) in Q2 2020, closing a stake of 591 shares — an estimated $3K sold.

Tradewinds Capital Management first reported a position in MBOT in Q2 2017 and held it in 2 quarters. The position peaked at $3K in Q1 2020. 23 funds tracked by Wall St. Rank hold MBOT as of Q2 2020.

  • Tradewinds Capital Management reported no remaining Microbot Medical position as of Q2 2020 after selling out during the quarter.
  • Tradewinds Capital Management sold 591 Microbot Medical shares in Q2 2020, an estimated $3K.
  • Tradewinds Capital Management first reported a position in Microbot Medical in Q2 2017 and held it in 2 quarters.
  • Tradewinds Capital Management's Microbot Medical position peaked at $3K in Q1 2020.
  • 23 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2020.

Based on Tradewinds Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.